PATUSKY CHRISTOPHER sold UTHR
April 24, 2026 · Form 4 insider transaction
PATUSKY CHRISTOPHER sold 2,910 shares of United Therapeutics Corporation at $569.00 per share, a transaction worth $1.66M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,910
Price
$569.00
Total value
$1.66M
InsiderPATUSKY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 24, 2026
Filing dateApril 24, 2026
Shares owned after1,490
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.